| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 228.47B | 222.47B | 207.01B | 194.42B | 192.33B | 194.31B |
| Gross Profit | 40.26B | 37.84B | 36.95B | 33.51B | 32.11B | 31.32B |
| EBITDA | 11.03B | 11.68B | 11.01B | 9.07B | 10.09B | 7.00B |
| Net Income | 3.87B | 2.68B | 4.27B | 2.81B | 3.26B | 682.00M |
Balance Sheet | ||||||
| Total Assets | 128.97B | 120.92B | 101.96B | 92.68B | 82.18B | 82.27B |
| Cash, Cash Equivalents and Short-Term Investments | 8.80B | 8.45B | 8.12B | 11.19B | 9.67B | 8.95B |
| Total Debt | 35.39B | 34.24B | 21.66B | 15.15B | 9.31B | 11.21B |
| Total Liabilities | 68.86B | 61.80B | 47.65B | 41.15B | 34.28B | 37.90B |
| Stockholders Equity | 57.70B | 56.67B | 53.30B | 50.50B | 47.56B | 44.16B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -5.28B | -3.70B | 332.00M | 4.28B | 2.88B |
| Operating Cash Flow | 0.00 | 12.48B | 9.37B | 7.43B | 8.11B | 8.34B |
| Investing Cash Flow | 0.00 | -20.67B | -13.54B | -7.54B | -3.96B | -5.23B |
| Financing Cash Flow | 0.00 | 8.26B | 845.00M | 692.00M | -3.55B | -1.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥15.36B | 12.33 | ― | 1.43% | 10.77% | 131.68% | |
73 Outperform | ¥53.53B | 8.14 | ― | 3.20% | 4.98% | -10.23% | |
72 Outperform | ¥493.17B | 15.17 | 9.86% | 2.58% | 1.08% | 2.71% | |
64 Neutral | ¥319.67B | 12.27 | ― | 2.61% | 6.54% | 15.08% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥4.39T | 20.92 | 9.46% | 1.32% | 1.99% | -18.79% | |
46 Neutral | ¥37.62B | 21.75 | ― | 1.65% | -1.17% | -84.81% |